By individually accounting for disease-related factors such as CRP levels, use of common IBD-related medications, disease severity, baseline disease activity status, and baseline bowel resection history, we aimed to minimize potential confounding effects of disease characteristics on the outcomes. The gene discussed is CRP; the disease is inflammatory bowel disease.